Griseolutein T from Streptomyces seoulensis, newly identified via combined-culture with Tsukamurella pulmonis, as an efficacious therapeutic agent against multidrug-resistant bacteria
Sung-Jin Kawai, Shumpei Asamizu, Hiroaki R. Suzuki, Hiroyasu Onaka, Yoshichika Arakawa, Kouji Kimura, Makoto Ojika · 2025
Read Griseolutein T from Streptomyces seoulensis, newly identified via combined-culture with Tsukamurella pulmonis, as an efficacious therapeutic agent against multidrug-resistant bacteria by Sung-Jin Kawai, Shumpei Asamizu, Hiroaki R. Suzuki, Hiroyasu Onaka, Yoshichika Arakawa, Kouji Kimura, Makoto Ojika (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w4412156568.txt.
Description
Sung-Jin Kawai, Shumpei Asamizu, Hiroaki Suzuki, and colleagues discover new antibiotics by growing bacteria together. Their paper appeared in The Journal of Antibiotics in 2025. Microbes change what they produce when neighbours are present. The team paired a Streptomyces strain with a Tsukamurella partner.
The pairing yielded three new phenazine antibiotics, the griseoluteins T, C, and D. Two related known compounds appeared as well. One new compound, griseolutein T, is unstable and needed special handling. In tests it beat several clinical antibiotics against drug-resistant staph, resistant enterococci, and Clostridioides difficile. It also showed low toxicity to human cells. Combined culture thus remains a rich route to new drug leads.
Catalog record
| CREATOR | Sung-Jin Kawai, Shumpei Asamizu, Hiroaki R. Suzuki, Hiroyasu Onaka, Yoshichika Arakawa, Kouji Kimura, Makoto Ojika |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / The Journal of Antibiotics |